+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

North America Histology and Cytology Market Size, Share & Trends Analysis Report By Type, By Product (Consumable & Reagents, and Instruments & Analysis Software System), By Test Type, By Application, By End User, By Country and Growth Forecast, 2024 - 2031

  • PDF Icon

    Report

  • 136 Pages
  • April 2024
  • Region: North America
  • Marqual IT Solutions Pvt. Ltd (KBV Research)
  • ID: 5967229
The North America Histology and Cytology Market would witness market growth of 13.1% CAGR during the forecast period (2024-2031).

The US market dominated the North America Histology and Cytology Market by Country in 2023, and would continue to be a dominant market till 2031; thereby, achieving a market value of $11,870.4 million by 2031. The Canada market is experiencing a CAGR of 15.6% during (2024 - 2031). Additionally, The Mexico market would exhibit a CAGR of 14.6% during (2024 - 2031).



The market encompasses a crucial healthcare industry segment, providing indispensable tools and techniques for understanding cellular and tissue structures, identifying diseases, and guiding treatment decisions. Histology, the study of tissue structures at the microscopic level, has long been instrumental in diagnosing various medical conditions, ranging from cancers to infectious diseases. Similarly, cytology focuses on examining individual cells and is vital in early cancer detection through methods like Pap smears and liquid-based cytology. Over the years, advancements in staining techniques, imaging modalities, and automation have revolutionized the field, enabling more precise and efficient tissue and cellular specimen analyses. This has improved diagnostic accuracy and facilitated research into disease mechanisms and the development of novel therapeutic strategies.

Histology and cytology form the cornerstone of modern diagnostic medicine, providing indispensable insights into the cellular and tissue structures underlying various diseases. Histology involves the microscopic examination of tissue samples to discern abnormalities, while cytology focuses on individual cell analysis. These disciplines are essential for diagnosing conditions ranging from cancer to infectious diseases, guiding treatment decisions, and monitoring disease progression. Over time, technological advancements such as improved staining techniques, imaging modalities, and automation have transformed these fields, enhancing diagnostic accuracy and efficiency.

Furthermore, cancer is a significant concern in North America, with Mexico reporting it as the third leading cause of death. According to All.Can, over 195,000 new cases were registered in Mexico in 2020, with cervical, thyroid, colon, prostate, breast, and thyroid cancers being the most prevalent. The death rate from malignant tumors in Mexico has increased in the last decade, indicating a growing need for histology and cytology services in the region to diagnose and manage these diseases. Thus, as the population ages and chronic diseases become more common, the demand for these diagnostic services is expected to grow, emphasizing the importance of ensuring access to high-quality histology and cytology services in the region.

Based on Type of Examination, the market is segmented into Cytology, and Histology. Based on Product, the market is segmented into Consumable & Reagents, and Instruments & Analysis Software System. Based on Test Type, the market is segmented into Microscopy Methods, Flow Cytometry, and Molecular Genetic Methods. Based on Application, the market is segmented into Drug Discovery & Designing, Clinical Diagnostics, and Academic Research. Based on End User, the market is segmented into Pharma & Biotech Companies, Diagnostic Laboratories, CDMO, and Others. Based on countries, the market is segmented into U.S., Mexico, Canada, and Rest of North America.

List of Key Companies Profiled

  • Merck KGaA
  • Becton, Dickinson and Company
  • Hologic, Inc.
  • Trivitron Healthcare Pvt. Ltd.
  • Danaher Corporation
  • F. Hoffmann-La Roche Ltd.
  • Thermo Fisher Scientific, Inc.
  • Koninklijke Philips N.V.
  • Sysmex Corporation
  • Abbott Laboratories

Market Report Segmentation

By Type of Examination
  • Cytology
  • Histology
By Product
  • Consumable & Reagents
  • Instruments & Analysis Software System
By Test Type
  • Microscopy Methods
  • Flow Cytometry
  • Molecular Genetic Methods
By Application
  • Drug Discovery & Designing
  • Clinical Diagnostics
  • Academic Research
By End User
  • Pharma & Biotech Companies
  • Diagnostic Laboratories
  • CDMO
  • Others
By Country
  • US
  • Canada
  • Mexico
  • Rest of North America

Table of Contents

Chapter 1. Market Scope & Methodology
1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
1.4.1 North America Histology and Cytology Market, by Type of Examination
1.4.2 North America Histology and Cytology Market, by Product
1.4.3 North America Histology and Cytology Market, by Test Type
1.4.4 North America Histology and Cytology Market, by Application
1.4.5 North America Histology and Cytology Market, by End User
1.4.6 North America Histology and Cytology Market, by Country
1.5 Methodology for the research
Chapter 2. Market at a Glance
2.1 Key Highlights
Chapter 3. Market Overview
3.1 Introduction
3.1.1 Overview
3.1.1.1 Market Composition and Scenario
3.2 Key Factors Impacting the Market
3.2.1 Market Drivers
3.2.2 Market Opportunities
3.2.3 Market Restraints
3.2.4 Market Challenges
3.3 Porter Five Forces Analysis
Chapter 4. North America Histology and Cytology Market by Type of Examination
4.1 North America Cytology Market by Region
4.2 North America Histology Market by Region
Chapter 5. North America Histology and Cytology Market by Product
5.1 North America Consumable & Reagents Market by Country
5.2 North America Instruments & Analysis Software System Market by Country
Chapter 6. North America Histology and Cytology Market by Test Type
6.1 North America Microscopy Methods Market by Country
6.2 North America Flow Cytometry Market by Country
6.3 North America Molecular Genetic Methods Market by Country
Chapter 7. North America Histology and Cytology Market by Application
7.1 North America Drug Discovery & Designing Market by Country
7.2 North America Clinical Diagnostics Market by Country
7.3 North America Academic Research Market by Country
Chapter 8. North America Histology and Cytology Market by End User
8.1 North America Pharma & Biotech Companies Market by Country
8.2 North America Diagnostic Laboratories Market by Country
8.3 North America CDMO Market by Country
8.4 North America Others Market by Country
Chapter 9. North America Histology and Cytology Market by Country
9.1 US Histology and Cytology Market
9.1.1 US Histology and Cytology Market by Type of Examination
9.1.2 US Histology and Cytology Market by Product
9.1.3 US Histology and Cytology Market by Test Type
9.1.4 US Histology and Cytology Market by Application
9.1.5 US Histology and Cytology Market by End User
9.2 Canada Histology and Cytology Market
9.2.1 Canada Histology and Cytology Market by Type of Examination
9.2.2 Canada Histology and Cytology Market by Product
9.2.3 Canada Histology and Cytology Market by Test Type
9.2.4 Canada Histology and Cytology Market by Application
9.2.5 Canada Histology and Cytology Market by End User
9.3 Mexico Histology and Cytology Market
9.3.1 Mexico Histology and Cytology Market by Type of Examination
9.3.2 Mexico Histology and Cytology Market by Product
9.3.3 Mexico Histology and Cytology Market by Test Type
9.3.4 Mexico Histology and Cytology Market by Application
9.3.5 Mexico Histology and Cytology Market by End User
9.4 Rest of North America Histology and Cytology Market
9.4.1 Rest of North America Histology and Cytology Market by Type of Examination
9.4.2 Rest of North America Histology and Cytology Market by Product
9.4.3 Rest of North America Histology and Cytology Market by Test Type
9.4.4 Rest of North America Histology and Cytology Market by Application
9.4.5 Rest of North America Histology and Cytology Market by End User
Chapter 10. Company Profiles
10.1 Merck KGaA
10.1.1 Company Overview
10.1.2 Financial Analysis
10.1.3 Segmental and Regional Analysis
10.1.4 Research & Development Expense
10.1.5 SWOT Analysis
10.2 Becton, Dickinson, and Company
10.2.1 Company Overview
10.2.2 Financial Analysis
10.2.3 Segmental and Regional Analysis
10.2.4 Research & Development Expense
10.2.5 Recent strategies and developments:
10.2.5.1 Partnerships, Collaborations, and Agreements:
10.2.6 SWOT Analysis
10.3 Hologic, Inc.
10.3.1 Company Overview
10.3.2 Financial Analysis
10.3.3 Segmental and Regional Analysis
10.3.4 Research & Development Expenses
10.3.5 SWOT Analysis
10.4 Trivitron Healthcare Pvt. Ltd.
10.4.1 Company Overview
10.4.2 SWOT Analysis
10.5 Danaher Corporation
10.5.1 Company Overview
10.5.2 Financial Analysis
10.5.3 Segmental and Regional Analysis
10.5.4 Research & Development Expense
10.5.5 Recent strategies and developments:
10.5.5.1 Partnerships, Collaborations, and Agreements:
10.5.6 SWOT Analysis
10.6 F. Hoffmann-La Roche Ltd.
10.6.1 Company Overview
10.6.2 Financial Analysis
10.6.3 Segmental and Regional Analysis
10.6.4 Research & Development Expense
10.6.5 Recent strategies and developments:
10.6.5.1 Partnerships, Collaborations, and Agreements:
10.6.5.2 Product Launches and Product Expansions:
10.6.5.3 Trails and Approvals:
10.6.6 SWOT Analysis
10.7 Thermo Fisher Scientific, Inc.
10.7.1 Company Overview
10.7.2 Financial Analysis
10.7.3 Segmental and Regional Analysis
10.7.4 Research & Development Expenses
10.7.5 SWOT Analysis
10.8 Koninklijke Philips N.V.
10.8.1 Company Overview
10.8.2 Financial Analysis
10.8.3 Segmental and Regional Analysis
10.8.4 Research & Development Expense
10.8.5 SWOT Analysis
10.9 Sysmex Corporation
10.9.1 Company Overview
10.9.2 Financial Analysis
10.9.3 Regional Analysis
10.9.4 Research & Development Expense
10.9.5 SWOT Analysis
10.10. Abbott Laboratories
10.10.1 Company Overview
10.10.2 Financial Analysis
10.10.3 Segmental and Regional Analysis
10.10.4 Research & Development Expense
10.10.5 SWOT Analysis

Companies Mentioned

  • Merck KGaA
  • Becton, Dickinson and Company
  • Hologic, Inc.
  • Trivitron Healthcare Pvt. Ltd.
  • Danaher Corporation
  • F. Hoffmann-La Roche Ltd.
  • Thermo Fisher Scientific, Inc.
  • Koninklijke Philips N.V.
  • Sysmex Corporation
  • Abbott Laboratories

Methodology

Loading
LOADING...